Granules India, Glenmark Pharma rally 3% on drug approvals from USFDA Granules India got the nod for a painkiller, while Glenmark got it for Deferasirox tablets used in the treatment for chronic iron overload syndrome.
Feedback
GLENMARK 
Reputation: 2,149 • Jan 8, 2020 2:10 AM
Vote
Comment
Share
NSE:GLENMARK price when posted: 343.3